AKTS latest filing

Aktis Oncology, Inc. (AKTS) Latest Insider Activity & Form 4 Trackers

Latest Alert: Herrmann Ken (Director) Sold 4,856 Shares of AKTS

SEC Form 4 filings parsed and delivered to your inbox seconds after publication.

⚡ Missed the move? Google takes hours to index these filings, but our direct SEC pipeline delivers alerts instantly. Start your 2-week free trial to receive real-time, real-second email updates whenever AKTS insiders trade.

⚠️ DATA DELAYED BY 48 HOURS

Snapshot updated 2026-09-03T06:31:22.016145Z across 2472 tracked ticker pages.

Ticker Filing Date Company Insider Title Transaction Shares Price Total Value Position Size Change SEC Filing
AKTS 2026-07-21 Aktis Oncology, Inc. Herrmann Ken Director Sell 4,856 $24.56 $119,274.04 78.25% View Filing
AKTS 2026-07-20 Aktis Oncology, Inc. Herrmann Ken Director Sell 3,065 $25.21 $77,258.54 100.00% View Filing
AKTS 2026-07-10 Aktis Oncology, Inc. Ron-Bigger Shulamit Chief Operating Officer Sell 50,000 $27.75 $1,387,557.78 56.56% View Filing

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and direct SEC filing links
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

  • Everything in Standard
  • Instant delivery detection-to-outbound time averages 0.83 seconds
  • Alert intervals starting from one minute
  • Filter alerts by ticker
Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.